| Literature DB >> 26085965 |
Kaoru Sumida1, Noriko Sato2, Miho Ota3, Koji Sakai4, Yasumasa Nippashi1, Daichi Sone5, Kota Yokoyama2, Kimiteru Ito6, Norihide Maikusa3, Etsuko Imabayashi7, Hiroshi Matsuda7, Kei Yamada8, Miho Murata9, Akira Kunimatsu10, Kuni Ohtomo10.
Abstract
PURPOSE: We examined the temperature of the intraventricular cerebrospinal fluid (Tv) in patients with Parkinson's disease (PD) and those with multiple system atrophy (MSA) in comparison with healthy subjects, and we examined normal changes in this temperature with aging.Entities:
Keywords: Cerebrospinal fluid; Parkinson's disease; diffusion-weighted imaging thermometry; multiple system atrophy; temperature
Mesh:
Year: 2015 PMID: 26085965 PMCID: PMC4467774 DOI: 10.1002/brb3.340
Source DB: PubMed Journal: Brain Behav Impact factor: 2.708
Demographic and clinical characteristics of the healthy control subjects, PD patients, and MSA patients
| Variable | Male | Female | ||||||
|---|---|---|---|---|---|---|---|---|
| Control | PD | MSA |
| Control | PD | MSA |
| |
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |||
| No. of subjects | 27 | 19 | 17 | 37 | 17 | 17 | ||
| Age | 65.1 ± 9.0 | 68.1 ± 10.6 | 61.9 ± 9.3 | 0.17 | 67.4 ± 5.9 | 69.4 ± 4.4 | 65.5 ± 6.9 | 0.159 |
| Onset age | 64.9 ± 10.9 | 58.9 ± 9.7 | 0.16 | 65.5 ± 5.1 | 61.5 ± 6.6 | 0.056 | ||
| Disease duration (months) | 46.5 ± 25.1 | 31.5 ± 16.3 | 0.04 | 41.5 ± 26.6 | 44.5 ± 21.6 | 0.726 | ||
| L-Dopa equivalent dose (mg) | 283.9 ± 253.7 | 107.0 ± 258 | 0.05 | 274 ± 107.9 | 260 ± 289 | 0.854 | ||
| Hoehn and Yahr scale | 1.9 ± 0.8 | 1.4 ± 1.6 | 0.22 | 2.3 ± 0.8 | 1.8 ± 1.7 | 0.311 | ||
PD, Parkinson's disease; MSA, multiple system atrophy; SD, standard deviation.
Figure 1Measured ventricular CSF temperatures in male patients with PD (n = 19) and male patients with MSA (n = 17) compared to the normal male controls (n = 27). The ventricular CSF temperatures of the men with PD or MSA were significantly higher than those of the controls (P = 0.004 and P = 0.007, respectively).
Figure 2Measured ventricular CSF temperatures in female patients with PD (n = 17) or MSA (n = 17) compared to the normal female controls (n = 37). There were no significant differences between the PD or MSA patients and the controls.
Figure 3Correlation between age and ventricular CSF temperature in male controls. The dotted line indicates the result of linear fitting. Ventricular CSF temperature tends to decrease by age with a significant correlation controlling for ventricular volume.
Figure 4Correlation between age and ventricular CSF temperature in female controls. The dotted line indicates the result of linear fitting. There was no correlation between age and ventricular CSF temperature in female controls controlling for ventricular volume.